Envision Healthcare Corp (AMSG) Earning Somewhat Favorable Media Coverage, Report Shows

News headlines about Envision Healthcare Corp (NASDAQ:AMSG) have been trending somewhat positive on Friday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Envision Healthcare Corp earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.0244815802461 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

COPYRIGHT VIOLATION WARNING: “Envision Healthcare Corp (AMSG) Earning Somewhat Favorable Media Coverage, Report Shows” was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://transcriptdaily.com/2017/09/15/envision-healthcare-corp-amsg-earning-somewhat-favorable-media-coverage-report-shows.html.

Envision Healthcare Corp Company Profile

Envision Healthcare Corporation is a provider of healthcare services. The Company offers a range clinical solutions, including physician-led services, medical transportation, ambulatory services and post-acute services. The Company operates through three segments: physician services, medical transportation and ambulatory services.

Insider Buying and Selling by Quarter for Envision Healthcare Corp (NASDAQ:AMSG)

Receive News & Ratings for Envision Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply